[Skip to Content]
[Skip to Content Landing]

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With AdultsA Systematic Review and Meta-analysis

Educational Objective To systematically review the susceptibility to and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among children and adolescents compared with adults.
1 Credit CME
Key Points

Question  What is the evidence on the susceptibility to and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among children and adolescents compared with adults?

Findings  In this systematic review and meta-analysis including 32 studies, children and adolescents younger than 20 years had 44% lower odds of secondary infection with SARS-CoV-2 compared with adults 20 years and older; this finding was most marked in those younger than 10 to 14 years. Data were insufficient to conclude whether transmission of SARS-CoV-2 by children is lower than by adults.

Meaning  Preliminary evidence suggests that children have a lower susceptibility to SARS-CoV-2 infection compared with adults, but the role that children and adolescents play in transmission of this virus remains unclear.

Abstract

Importance  The degree to which children and adolescents are infected by and transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. The role of children and adolescents in transmission of SARS-CoV-2 is dependent on susceptibility, symptoms, viral load, social contact patterns, and behavior.

Objective  To systematically review the susceptibility to and transmission of SARS-CoV-2 among children and adolescents compared with adults.

Data Sources  PubMed and medRxiv were searched from database inception to July 28, 2020, and a total of 13 926 studies were identified, with additional studies identified through hand searching of cited references and professional contacts.

Study Selection  Studies that provided data on the prevalence of SARS-CoV-2 in children and adolescents (younger than 20 years) compared with adults (20 years and older) derived from contact tracing or population screening were included. Single-household studies were excluded.

Data Extraction and Synthesis  PRISMA guidelines for abstracting data were followed, which was performed independently by 2 reviewers. Quality was assessed using a critical appraisal checklist for prevalence studies. Random-effects meta-analysis was undertaken.

Main Outcomes and Measures  Secondary infection rate (contact-tracing studies) or prevalence or seroprevalence (population screening studies) among children and adolescents compared with adults.

Results  A total of 32 studies comprising 41 640 children and adolescents and 268 945 adults met inclusion criteria, including 18 contact-tracing studies and 14 population screening studies. The pooled odds ratio of being an infected contact in children compared with adults was 0.56 (95% CI, 0.37-0.85), with substantial heterogeneity (I2 = 94.6%). Three school-based contact-tracing studies found minimal transmission from child or teacher index cases. Findings from population screening studies were heterogenous and were not suitable for meta-analysis. Most studies were consistent with lower seroprevalence in children compared with adults, although seroprevalence in adolescents appeared similar to adults.

Conclusions and Relevance  In this meta-analysis, there is preliminary evidence that children and adolescents have lower susceptibility to SARS-CoV-2, with an odds ratio of 0.56 for being an infected contact compared with adults. There is weak evidence that children and adolescents play a lesser role than adults in transmission of SARS-CoV-2 at a population level. This study provides no information on the infectivity of children.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: August 23, 2020.

Published Online: September 25, 2020. doi:10.1001/jamapediatrics.2020.4573

Correction: This article was corrected on November 2, 2020, to add the Funding/Support and Role of the Funder/Sponsor sections and fix the degree for Jasmina Panovska-Griffiths.

Corresponding Author: Russell M. Viner, PhD, UCL Great Ormond Street Institute of Child Health, 30 Guilford St, London WC1N 1EH, United Kingdom (r.viner@ucl.ac.uk).

Author Contributions: Dr Viner had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Viner, Bonell, Hudson, Eggo.

Acquisition, analysis, or interpretation of data: Viner, Mytton, Bonell, Melendez-Torres, Ward, Waddington, Thomas, Russell, van der Klis, Koirala, Ladhani, Panovska-Griffiths, Davies, Booy, Eggo.

Drafting of the manuscript: Viner, Mytton, Bonell, Melendez-Torres, Waddington, Thomas, Eggo.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Viner, Melendez-Torres, Waddington, Thomas, Russell, Booy, Eggo.

Administrative, technical, or material support: Viner, Mytton, Waddington, Koirala.

Study supervision: Viner, Bonell, Eggo.

Conflict of Interest Disclosures: Dr Mytton has received grants from the National Institute of Health Research and personal fees from Public Health England. No other disclosures were reported.

Funding/Support: Dr Eggo was supported by grant MR/S003975/1 from Health Data Research UK and grant MC_PC 19065 from the Medical Research Council.

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

References
1.
Lee  PI , Hu  YL , Chen  PY , Huang  YC , Hsueh  PR .  Are children less susceptible to COVID-19?   J Microbiol Immunol Infect. 2020;53(3):371-372. doi:10.1016/j.jmii.2020.02.011PubMedGoogle ScholarCrossref
2.
Munro  APS , Faust  SN .  Children are not COVID-19 super spreaders: time to go back to school.   Arch Dis Child. 2020;105(7):618-619. doi:10.1136/archdischild-2020-319474PubMedGoogle ScholarCrossref
3.
Brurberg  KG .  The Role of Children in the Transmission of SARS-CoV-2 (COVID-19), 1st Update—A Rapid Review. Norwegian Institute of Public Health; 2020.
4.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention.  The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.  Article in Chinese.  Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-151.PubMedGoogle Scholar
5.
Docherty  AB , Harrison  EM , Green  CA ,  et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation protocol. medRxiv. Preprint posted online April 28, 2020. doi:10.1101/2020.04.23.20076042
6.
CDC COVID-19 Response Team.  Coronavirus disease 2019 in children—United States, February 12-April 2, 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(14):422-426. doi:10.15585/mmwr.mm6914e4PubMedGoogle ScholarCrossref
7.
National Institute for Public Health and the Environment. Children and schools. Accessed July 20, 2020. https://www.rivm.nl/en/novel-coronavirus-covid-19/children-and-covid-19
8.
COVID-19 National Incident Room Surveillance Team.  COVID-19, Australia: epidemiology report 13 (reporting week to 23:59 AEST 26 April 2020).   Commun Dis Intell. Published online May 1, 2020. doi:10.33321/cdi.2020.44.35PubMedGoogle Scholar
9.
Ricardo  F , Ajelli  M , Andrianou  X ,  et al. Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic. medRxiv. Preprint posted online April 11, 2020. doi:10.1101/2020.04.08.20056861
10.
Zhang  J , Litvinova  M , Liang  Y ,  et al.  Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China.   Science. 2020;368(6498):1481-1486. doi:10.1126/science.abb8001PubMedGoogle ScholarCrossref
11.
Bi  Q , Wu  Y , Mei  S ,  et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.   Lancet Infect Dis. 2020;20(8):911-919. doi:10.1016/S1473-3099(20)30287-5PubMedGoogle ScholarCrossref
12.
Park  YJ , Choe  YJ , Park  O ,  et al; COVID-19 National Emergency Response Center, Epidemiology and Case Management Team.  Contact tracing during coronavirus disease outbreak, South Korea, 2020.   Emerg Infect Dis. 2020;26(10). doi:10.3201/eid2610.201315PubMedGoogle Scholar
13.
Kim  J , Choe  YJ , Lee  J ,  et al.  Role of children in household transmission of COVID-19.   Arch Dis Child. Published online August 7, 2020. doi:10.1136/archdischild-2020-319910PubMedGoogle Scholar
14.
Li  X , Xu  W , Dozier  M , He  Y , Kirolos  A , Theodoratou  E ; UNCOVER.  The role of children in transmission of SARS-CoV-2: a rapid review.   J Glob Health. 2020;10(1):011101. doi:10.7189/jogh.10.011101PubMedGoogle Scholar
15.
Joanna Briggs Institute. Checklist for prevalence studies. Accessed June 8, 2020. https://joannabriggs.org/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Prevalence_Studies2017_0.pdf
16.
Li  W , Zhang  B , Lu  J ,  et al.  The characteristics of household transmission of COVID-19.   Clin Infect Dis. Published online April 17, 2020. doi:10.1093/cid/ciaa450PubMedGoogle Scholar
17.
Cheng  HY , Jian  SW , Liu  DP , Ng  TC , Huang  WT , Lin  HH ; Taiwan COVID-19 Outbreak Investigation Team.  Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.   JAMA Intern Med. 2020;180(9):1156-1163. doi:10.1001/jamainternmed.2020.2020PubMedGoogle ScholarCrossref
18.
Wang  Z , Ma  W , Zheng  X , Wu  G , Zhang  R .  Household transmission of SARS-CoV-2.   J Infect. 2020;81(1):179-182. doi:10.1016/j.jinf.2020.03.040PubMedGoogle ScholarCrossref
19.
Mizumoto  K , Omori  R , Nishiura  H . Age specificity of cases and attack rate of novel coronavirus disease (COVID-19). medRxiv. Preprint posted online March 13, 2020. doi:10.1101/2020.03.09.20033142
20.
Wang  Y , Tian  H , Zhang  L ,  et al.  Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China.   BMJ Glob Health. 2020;5(5):e002794. doi:10.1136/bmjgh-2020-002794PubMedGoogle Scholar
21.
Dattner  I , Goldberg  Y , Katriel  G ,  et al. The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. medRxiv. Preprint posted online June 5, 2020. doi:10.1101/2020.06.03.20121145
22.
Hu  S , Wang  W , Wang  Y ,  et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. medRxiv. Preprint posted online August 7, 2020. doi:10.1101/2020.07.23.20160317
23.
Laxminarayan  R , Wahl  B , Dudala  SR ,  et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. medRxiv. Preprint posted online July 17, 2020. doi:10.1101/2020.07.14.20153643
24.
Liu  T , Liang  W , Zhong  H ,  et al.  Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing.   Emerg Microbes Infect. 2020;9(1):1546-1553. doi:10.1080/22221751.2020.1787799PubMedGoogle ScholarCrossref
25.
Rosenberg  ES , Dufort  EM , Blog  DS ,  et al; New York State Coronavirus 2019 Response Team.  COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State—March 2020.   Clin Infect Dis. Published online May 8, 2020. doi:10.1093/cid/ciaa549PubMedGoogle Scholar
26.
Yousaf  AR , Duca  LM , Chu  V ,  et al.  A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time.   Clin Infect Dis. Published online July 28, 2020. doi:10.1093/cid/ciaa1072PubMedGoogle Scholar
27.
Chaw  L , Koh  WC , Jamaludin  SA , Naing  L , Alikhan  MF , Wong  J . SARS-CoV-2 transmission in different settings: analysis of cases and close contacts from the Tablighi cluster in Brunei Darussalam. medRxiv. Preprint posted online July 10, 2020. doi:10.1101/2020.05.04.20090043
28.
van der Hoek  W , Backer  JA , Bodewes  R ,  et al.  The role of children in the transmission of SARS-CoV-2.  Article in Dutch.  Ned Tijdschr Geneeskd. 2020;164:D5140.PubMedGoogle Scholar
29.
Macartney  K , Quinn  HE , Pillsbury  AJ ,  et al; NSW COVID-19 Schools Study Team.  Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study.   Lancet Child Adolesc Health. Published online August 3, 2020. doi:10.1016/S2352-4642(20)30251-0PubMedGoogle Scholar
30.
Heavey  L , Casey  G , Kelly  C , Kelly  D , McDarby  G .  No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020.   Euro Surveill. 2020;25(21):2000903. doi:10.2807/1560-7917.ES.2020.25.21.2000903PubMedGoogle Scholar
31.
Yung  CF , Kam  KQ , Nadua  KD ,  et al.  Novel coronavirus 2019 transmission risk in educational settings.   Clin Infect Dis. Published online June 25, 2020. doi:10.1093/cid/ciaa794PubMedGoogle Scholar
32.
Gudbjartsson  DF , Helgason  A , Jonsson  H ,  et al.  Spread of SARS-CoV-2 in the Icelandic population.   N Engl J Med. 2020;382(24):2302-2315. doi:10.1056/NEJMoa2006100PubMedGoogle ScholarCrossref
33.
Lavezzo  E , Franchin  E , Ciavarella  C ,  et al; Imperial College COVID-19 Response Team.  Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’.   Nature. 2020;584(7821):425-429. doi:10.1038/s41586-020-2488-1PubMedGoogle ScholarCrossref
34.
Public Health Agency of Sweden. Förekomsten av covid-19 i Sverige 21-24 april och 25-28 maj 2020. Accessed July 28, 2020. https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/f/forekomsten-av-covid-19-i-sverige-21-24-april-och-25-28-maj-2020/
35.
Office for National Statistics. Coronavirus (COVID-19) infection survey pilot: England and Wales, 11 September 2020. Accessed July 28, 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/11september2020
36.
Pollán  M , Pérez-Gómez  B , Pastor-Barriuso  R ,  et al; ENE-COVID Study Group.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.   Lancet. 2020;396(10250):535-544. doi:10.1016/S0140-6736(20)31483-5PubMedGoogle ScholarCrossref
37.
National Institute for Public Health and the Environment. PIENTER Corona study. Accessed September 16, 2020. https://www.rivm.nl/en/pienter-corona-study
38.
Hallal  P , Hartwig  F , Horta  B ,  et al. Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states. medRxiv. Preprint posted online May 30, 2020. doi:10.1101/2020.05.30.20117531
39.
Shakiba  M , Hashemi Nazari  SS , Mehrabian  F , Rezvani  SM , Ghasempour  Z , Heidarzadeh  A . Seroprevalence of COVID-19 virus infection in Guilan province, Iran. medRxiv. Preprint posted online May 1, 2020. doi:10.1101/2020.04.26.20079244
40.
Biggs  HM , Harris  JB , Breakwell  L ,  et al; CDC Field Surveyor Team.  Estimated community seroprevalence of SARS-CoV-2 antibodies—two Georgia counties, April 28-May 3, 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(29):965-970. doi:10.15585/mmwr.mm6929e2PubMedGoogle ScholarCrossref
41.
Stringhini  S , Wisniak  A , Piumatti  G ,  et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.   Lancet. 2020;396(10247):313-319. doi:10.1016/S0140-6736(20)31304-0PubMedGoogle ScholarCrossref
42.
Nawa  N , Kuramochi  J , Sonoda  S ,  et al. Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study. medRxiv. Preprint posted online July 26, 2020. doi:10.1101/2020.07.20.20155945
43.
Pagani  G , Conti  F , Giacomelli  A ,  et al. Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA). medRxiv. Preprint posted online August 28, 2020. doi:10.1101/2020.06.24.20138875
44.
Weis  S , Scherag  A , Baier  M ,  et al. Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak—the CoNAN study. medRxiv. Preprint posted online July 17, 2020. doi:10.1101/2020.07.15.20154112
45.
Streeck  H , Schulte  B , Kuemmerer  B ,  et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. medRxiv. Preprint posted online June 2, 2020. doi:10.1101/2020.05.04.20090076
46.
Davies  NG , Klepac  P , Liu  Y , Prem  K , Jit  M , Eggo  RM ; CMMID COVID-19 Working Group.  Age-dependent effects in the transmission and control of COVID-19 epidemics.   Nat Med. 2020;26(8):1205-1211. doi:10.1038/s41591-020-0962-9PubMedGoogle ScholarCrossref
47.
Torres  JP , Piñera  C , De La Maza  V ,  et al.  SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study.   Clin Infect Dis. Published only July 10, 2020. doi:10.1093/cid/ciaa955PubMedGoogle Scholar
48.
Fontanet  A , Tondeur  L , Madec  Y ,  et al. Cluster of COVID-19 in northern France: a retrospective closed cohort study. medRxiv. Preprint posted online April 23, 2020. doi:10.1101/2020.04.18.20071134
49.
Zhu  Y , Bloxham  CJ , Hulme  KD ,  et al. Children are unlikely to have been the primary source of household SARS-CoV-2 infections. medRxiv. Preprint posted online March 30, 2020. doi:10.1101/2020.03.26.20044826
50.
Sun  K , Viboud  C .  Impact of contact tracing on SARS-CoV-2 transmission.   Lancet Infect Dis. 2020;20(8):876-877. doi:10.1016/S1473-3099(20)30357-1PubMedGoogle ScholarCrossref
51.
Jing  QL , Liu  MJ , Zhang  ZB ,  et al.  Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.   Lancet Infect Dis. Published online June 17, 2020. doi:10.1016/S1473-3099(20)30471-0PubMedGoogle Scholar
52.
Wu  J , Huang  Y , Tu  C ,  et al.  Household transmission of SARS-CoV-2, Zhuhai, China, 2020.   Clin Infect Dis. Published online May 11, 2020. doi:10.1093/cid/ciaa557PubMedGoogle Scholar
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 CME points in the American Board of Surgery’s (ABS) Continuing Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close